Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
International Journal of Clinical Endocrinology and Metabolism · 2017
DOI: 10.17352/ijcem.000025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Endocrinology and Metabolism, 2017. Verfasst von AT El Gammal und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
S100A8/A9 expression has been linked to carcinogenesis and infl ammation.We hypothesized that S100A8/A9 protein serum levels are a useful stratifi cation marker for patients with pancreatic ductal adenocarcinoma (PDAC), intraductal papillary mucinous neoplasm (IPMN) or chronic pancreatitis (CP).
Methods
S100A8/A9 serum levels were analysed in PDAC, CP and IPMN patients and compared to S100A8/A9 healthy donor controls (HD) using ELISA.S100A8/A9 levels and clinical data were statistically analysed.
Results
Out of 134 patients included, 84 were diagnosed with PDAC (46%), 30 patients with IPMN (16%) and 20 patients with CP (11%), 50 patients were HD (27%).When compared to HD (343.3 ng/ml), S100A8/A9 serum concentration was elevated in PDAC (402.0 ng/ml, p = 0.001) and CP patients (426.51 ng/ml p < 0.001).Also, S100A8/A9 levels were elevated in PDAC compared to IPMN group (369.0 ng/ml p = 0.026) and in CP compared to IPMN group (p = 0.001).A multivariate model including age, gender, leukocyte levels, C-reactive protein (CrP), S100A8/A9 and CA 19-9 concentrations reported a diagnostic sensitivity of 74.8%.
Conclusion
S100A8/A9 serum levels are increased in patients with PDAC, CP, and IPMN and might be useful to distinguish malignant and infl ammatory diseases from normal and non-malignant pathological conditions.
Zitieren
APA
Gammal, A. E., Sturm, J., Pinnschmidt, H., Hofmann, B., & Bellon, E. (2017). Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases. International Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.17352/ijcem.000025
Vancouver
Gammal AE, Sturm J, Pinnschmidt H, Hofmann B, Bellon E. Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases. International Journal of Clinical Endocrinology and Metabolism. 2017. doi:10.17352/ijcem.000025
BibTeX
@article{Gammal2017,
author = {Gammal, AT El and Sturm, JH and Pinnschmidt, HO and Hofmann, BT and Bellon, E},
title = {Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases},
journal = {International Journal of Clinical Endocrinology and Metabolism},
year = {2017},
doi = {10.17352/ijcem.000025}
}
EUVIMED